14 results
8-K
EX-2.1
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
or other ineligibility and are not currently listed on the General Services Administration published list of parties excluded from federal procurement … programs and non-procurement programs.
(b) As of the date of this Agreement, there is no pending or, to Seller’s Knowledge, threatened investigation
10-K
2019 FY
MIRM
Mirum Pharmaceuticals Inc
12 Mar 20
Annual report
4:16pm
into government procurement contracts governed by the Federal Acquisition Regulations. If our products are made available to authorized users of the Federal
424B4
jio18p65
9 Jan 20
Prospectus supplement with pricing info
5:11pm
DRS
k0tq6k37k08ohzv9x1ys
27 Dec 19
Draft registration statement
12:00am
424B4
qid5c9i k4visp0lap
18 Jul 19
Prospectus supplement with pricing info
4:04pm
S-1
61eyos3
21 Jun 19
IPO registration
3:24pm
DRS/A
t8bpp7zn nhb46
24 May 19
Draft registration statement (amended)
12:00am
DRS
hsvz6xp4ij3binf2u
18 Apr 19
Draft registration statement
12:00am
- Prev
- 1
- Next